23andMe to go public via Richard Branson’s SPAC February 4, 2021 San Francisco Biotechnology Network News News Comments Off on 23andMe to go public via Richard Branson’s SPAC The genetics testing company 23andMe will enter the public markets via a SPAC sponsored by Virgin Group founder Richard Branson. Click to view original post Health Techfinancegeneticsmedical technology